Development of Mitotane Lipid Nanocarriers and Enantiomers: Two-in-One Solution to Efficiently Treat Adreno-Cortical Carcinoma

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|19|34|5854-5862

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.19, Iss.34, 2012-12, pp. : 5854-5862

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A fly in the ointment: reassessing mitotane’s role in the treatment of adrenocortical carcinoma

By Bapat Aditi A Demeure Michael J Bussey Kimberly J

Pharmacogenomics, Vol. 13, Iss. 11, 2012-08 ,pp. : 1207-1209

Future Medicine

Access to resources Recommend Favorite

Development and Tailoring of Hybrid Lipid Nanocarriers

Current Pharmaceutical Design, Vol. 23, Iss. 43, 2018-02 ,pp. : 6643-6658

Bentham Science Publishers

Access to resources Recommend Favorite

Management of Adrenocortical Carcinoma

By Strosberg Jonathan R. Hammer Gary D. Doherty Gerard M.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 7, Iss. 7, 2009-07 ,pp. : 752-759

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Development of microemulsion of mitotane for improvement of oral bioavailability

By Attivi David Ajana Imane Astier Alain Demoré Béatrice Gibaud Stéphane

Drug Development and Industrial Pharmacy, Vol. 36, Iss. 4, 2010-04 ,pp. : 421-427

Informa Healthcare

Access to resources Recommend Favorite

Hydrophilic coating of mitotane-loaded lipid nanoparticles: Preliminary studies for mucosal adhesion

By Severino Patrícia Souto Eliana B. Pinho Samantha C.

Pharmaceutical Development and Technology, Vol. 18, Iss. 3, 2013-06 ,pp. : 577-581

Informa Healthcare

Access to resources Recommend Favorite